A company insider recently sold 5,908 shares of Amedisys Inc. [AMED]. Should You also Consider to Sale?


Amedisys Inc.’s recent filing unveils that its Chief Information Officer North Michael Paul unloaded Company’s shares for reported $0.51 million on Mar 03. In the deal valued at $86.43 per share,5,908 shares were sold. As a result of this transaction, North Michael Paul now holds 4,164 shares worth roughly $ 0.39 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Truist downgraded its Amedisys Inc. [AMED] rating to a Hold from a a Buy in a research note published on Tuesday. PT values the company’s stock at a premium of 3.23 to its Tuesday closing price.

Price Performance Review of AMED

On Tuesday, Amedisys Inc. [NASDAQ:AMED] saw its stock jump 0.02% to $93.87. On the same session, the stock had its day’s lowest price of $93.63, but rose to a high of $93.96. Over the last five days, the stock has gained 0.09%. Amedisys Inc. shares have risen nearly 12.37% since the year began. Nevertheless, the stocks have fallen -18.22% over the past one year. While a 52-week high of $126.81 was reached on 02/16/23, a 52-week low of $69.36 was recorded on 03/23/23. SMA at 50 days reached $91.90, while 200 days put it at $86.28. A total of 0.68 million shares were traded, compared to the trading of 0.5 million shares in the previous session.

Levels Of Support And Resistance For AMED Stock

The 24-hour chart illustrates a support level at 93.68, which if violated will result in even more drops to 93.49. On the upside, there is a resistance level at 94.01. A further resistance level may holdings at 94.15. The Relative Strength Index (RSI) on the 14-day chart is 69.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 21.05%. Stochastics %K at 78.41% indicates the stock is a holding.

How much short interest is there in Amedisys Inc.?

A steep rise in short interest was recorded in Amedisys Inc. stocks on Aug 14, 2023, growing by 100000.0 shares to a total of 1.37 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.27 million shares. There was a rise of 7.3%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.92% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.71.

Amedisys Inc. [AMED] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 3,182,499 shares, or roughly 9.76% of the outstanding AMED shares. In other words, the investor’s shares have fallen by -2,487 from its previous 13-F filing of 3184986.0. Additionally, BlackRock Fund Advisors decreased -2.72% of its stake after which the total value it holdings stand at $238,048,854, while Deerfield Management Co. LP added 20.96% of its stake to hold $162.97 million in the firm. Over the last quarter, Wellington Management Co. LLP sold -1,015,852 shares of Amedisys Inc., while Riverbridge Partners LLC sold 34,261 shares. At present, Mackenzie Financial Corp. is holding 942,657 shares valued at $85.63 million. SSgA Funds Management, Inc. owned 928,633 shares of the company at the time of its most recent 13F filing, worth $84.36 million.

According to FactSet, Amedisys Inc.’s share price will average $100.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 7.62 percent from its previous closing price of $93.85. Analysts expect Amedisys Inc. stock to reach the higher price of $101.00, while the lowest price estimate is $97.00. However, 14 analysts have rated AMED stock as a Hold in their predictions for 2023.


Please enter your comment!
Please enter your name here